Camden National Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.48M | Buy |
9,869
+617
| +7% | +$133K | 0.32% | 67 |
|
|
2026
Q1 | $2.01M | Sell |
9,252
-199
| -2% | -$44.1K | 0.27% | 67 |
|
|
2025
Q4 | $2.16M | Buy |
9,451
+22
| +0.2% | +$5.01K | 0.3% | 67 |
|
|
2025
Q3 | $2.18M | Sell |
9,429
-490
| -5% | -$99.8K | 0.31% | 67 |
|
|
2025
Q2 | $1.84M | Sell |
9,919
-910
| -8% | -$169K | 0.27% | 68 |
|
|
2025
Q1 | $2.27M | Buy |
10,829
+320
| +3% | +$62.2K | 0.34% | 68 |
|
|
2024
Q4 | $1.87M | Buy |
10,509
+673
| +7% | +$124K | 0.28% | 68 |
|
|
2024
Q3 | $1.94M | Sell |
9,836
-150
| -2% | -$28K | 0.28% | 68 |
|
|
2024
Q2 | $1.71M | Buy |
9,986
+1,985
| +25% | +$329K | 0.26% | 70 |
|
|
2024
Q1 | $1.46M | Sell |
8,001
-235
| -3% | -$40.5K | 0.26% | 70 |
|
|
2023
Q4 | $1.28M | Sell |
8,236
-619
| -7% | -$90.2K | 0.24% | 67 |
|
|
2023
Q3 | $1.32M | Buy |
8,855
+101
| +1% | +$14.8K | 0.27% | 65 |
|
|
2023
Q2 | $1.18M | Sell |
8,754
-271
| -3% | -$39.7K | 0.23% | 68 |
|
|
2023
Q1 | $1.44M | Sell |
9,025
-1,081
| -11% | -$165K | 0.29% | 66 |
|
|
2022
Q4 | $1.63M | Sell |
10,106
-835
| -8% | -$128K | 0.34% | 66 |
|
|
2022
Q3 | $1.47M | Sell |
10,941
-155
| -1% | -$22.2K | 0.33% | 67 |
|
|
2022
Q2 | $1.7M | Sell |
11,096
-360
| -3% | -$55K | 0.35% | 67 |
|
|
2022
Q1 | $1.86M | Sell |
11,456
-417
| -4% | -$60.6K | 0.34% | 68 |
|
|
2021
Q4 | $1.61M | Sell |
11,873
-68
| -0.6% | -$8.03K | 0.28% | 69 |
|
|
2021
Q3 | $1.29M | Buy |
11,941
+270
| +2% | +$30.9K | 0.25% | 67 |
|
|
2021
Q2 | $1.31M | Buy |
11,671
+205
| +2% | +$23.1K | 0.25% | 69 |
|
|
2021
Q1 | $1.24M | Buy |
11,466
+542
| +5% | +$58K | 0.25% | 67 |
|
|
2020
Q4 | $1.17M | Buy |
10,924
+245
| +2% | +$23.5K | 0.24% | 66 |
|
|
2020
Q3 | $935K | Buy |
10,679
+723
| +7% | +$68.1K | 0.21% | 65 |
|
|
2020
Q2 | $977K | Buy |
9,956
+97
| +1% | +$8.54K | 0.24% | 62 |
|
|
2020
Q1 | $751K | Sell |
9,859
-219
| -2% | -$18.7K | 0.2% | 65 |
|
|
2019
Q4 | $893K | Sell |
10,078
-101
| -1% | -$8.38K | 0.18% | 64 |
|
|
2019
Q3 | $771K | Buy |
10,179
+598
| +6% | +$41K | 0.17% | 65 |
|
|
2019
Q2 | $697K | Sell |
9,581
-254
| -3% | -$20K | 0.16% | 65 |
|
|
2019
Q1 | $792K | Sell |
9,835
-50
| -0.5% | -$4.09K | 0.19% | 57 |
|
|
2018
Q4 | $912K | Sell |
9,885
-565
| -5% | -$49.7K | 0.25% | 50 |
|
|
2018
Q3 | $988K | Sell |
10,450
-95
| -0.9% | -$9.01K | 0.24% | 52 |
|
|
2018
Q2 | $977K | Buy |
10,545
+20
| +0.2% | +$1.95K | 0.26% | 48 |
|
|
2018
Q1 | $996K | Sell |
10,525
-57
| -0.5% | -$6.26K | 0.29% | 44 |
|
|
2017
Q4 | $1.02M | Buy |
10,582
+1,093
| +12% | +$103K | 0.3% | 43 |
|
|
2017
Q3 | $843K | Sell |
9,489
-220
| -2% | -$16.7K | 0.25% | 44 |
|
|
2017
Q2 | $704K | Sell |
9,709
-185
| -2% | -$12.4K | 0.22% | 44 |
|
|
2017
Q1 | $645K | Buy |
9,894
+510
| +5% | +$32.1K | 0.2% | 47 |
|
|
2016
Q4 | $587K | Buy |
+9,384
| New | +$573K | 0.18% | 49 |
|
Other funds holding ABBV
Camden National Bank's ABBV Position: Q2 2026 in Review
Camden National Bank increased its AbbVie (ABBV) stake by 6.7% in Q2 2026, buying an estimated $133K and bringing the position to 9,869 shares worth $2.48M. The position accounts for 0.32% of the portfolio, ranked #67.
Camden National Bank first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Camden National Bank held 9,869 shares of AbbVie worth $2.48M as of Q2 2026.
- Camden National Bank bought 617 AbbVie shares in Q2 2026, an estimated $133K.
- AbbVie made up 0.32% of Camden National Bank's portfolio in Q2 2026, its #67 holding.
- Camden National Bank first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Camden National Bank's 13F filing for Q2 2026, filed 31 Jul 2026.